Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment

by Parker, David, Belaud-Rotureau, Marc-Antoine
Published 2014

Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer

by Lavoué, Vincent, Thédrez, Aurélie, Levêque, Jean, Foucher, Fabrice, Henno, Sébastien, Jauffret, Vincent, Belaud-Rotureau, Marc-Antoine, Catros, Veronique, Cabillic, Florian
Published 2013

FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients

by Hagedorn, Martin, Delugin, Maylis, Abraldes, Isabelle, Allain, Nathalie, Belaud-Rotureau, Marc-Antoine, Turmo, Michelle, Prigent, Claude, Loiseau, Hugues, Bikfalvi, Andréas, Javerzat, Sophie
Published 2007

Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma

by Verhoest, Grégory, Dolley-Hitze, Thibault, Jouan, Florence, Belaud-Rotureau, Marc-Antoine, Oger, Emmanuel, Lavenu, Audrey, Bensalah, Karim, Arlot-Bonnemains, Yannick, Collet, Nicolas, Rioux-Leclercq, Nathalie, Vigneau, Cécile
Published 2014

Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology

by Jaillard, Sylvie, Akloul, Linda, Beaumont, Marion, Hamdi-Roze, Houda, Dubourg, Christele, Odent, Sylvie, Duros, Solène, Dejucq-Rainsford, Nathalie, Belaud-Rotureau, Marc-Antoine, Ravel, Célia
Published 2016